Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
The new online Learning Center with new content can still be found under the “Training” folder on ...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...